作者
Marco Colizzi, Elena Carra, Sara Fraietta, John Lally, Diego Quattrone, Stefania Bonaccorso, Valeria Mondelli, Olesya Ajnakina, Paola Dazzan, Antonella Trotta, Lucia Sideli, Anna Kolliakou, Fiona Gaughran, Mizanur Khondoker, Anthony S David, Robin M Murray, James H MacCabe, Marta Di Forti
发表日期
2016/2/1
期刊
Schizophrenia research
卷号
170
期号
2-3
页码范围
311-317
出版商
Elsevier
简介
Both substance use and poor medication adherence are associated with poor outcome in psychosis. To clarify the contributions of substance use and poor medication adherence to poor outcome in the year following a first episode of psychosis, 205 patients were evaluated for use of tobacco, alcohol, cannabis and stimulants at their psychosis onset, and in a 1-year follow-up. Data on medication adherence and symptom remission were also collected. Patients had high rates of overall substance use before (37–65%) and after psychosis onset (45–66%). 44% showed poor medication adherence and 55% did not reach remission from psychosis. Nicotine dependence and cannabis use after psychosis onset significantly predicted both poor medication adherence and non-remission, and poor medication adherence mediated the effects of these substances on non-remission. In conclusion, medication adherence lies …
引用总数
2016201720182019202020212022202320241817121310794
学术搜索中的文章